Literature DB >> 23139249

Association between use of specialty dietary supplements and C-reactive protein concentrations.

Elizabeth D Kantor1, Johanna W Lampe, Thomas L Vaughan, Ulrike Peters, Colin D Rehm, Emily White.   

Abstract

Laboratory evidence suggests that certain specialty dietary supplements have antiinflammatory properties, though evidence in humans remains limited. Data on a nationally representative sample of 9,947 adults from the 1999-2004 cycles of the National Health and Nutrition Examination Survey were used to assess the associations between specialty supplement use and inflammation, as measured by serum high-sensitivity C-reactive protein (hs-CRP) concentration. Using survey-weighted multivariate linear regression, significant reductions in hs-CRP concentrations were associated with regular use of glucosamine (17%, 95% confidence interval (CI): 7, 26), chondroitin (22%, 95% CI: 8, 33), and fish oil (16%, 95% CI: 0.3, 29). No associations were observed between hs-CRP concentration and regular use of supplements containing methylsulfonylmethane, garlic, ginkgo biloba, saw palmetto, or pycnogenol. These results suggest that glucosamine and chondroitin supplements are associated with reduced inflammation in humans and provide further evidence to support an inverse association between use of fish oil supplements and inflammation. It is important to further investigate the potential antiinflammatory role of these supplements, as there is a need to identify safe and effective ways to reduce inflammation and the burden of inflammation-related diseases such as cancer and cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23139249      PMCID: PMC3571242          DOI: 10.1093/aje/kws186

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  89 in total

1.  Grape-seed procyanidins modulate inflammation on human differentiated adipocytes in vitro.

Authors:  Matilde R Chacón; Victòria Ceperuelo-Mallafré; Elsa Maymó-Masip; Josep Maria Mateo-Sanz; Lluis Arola; Cristina Guitiérrez; José Manuel Fernandez-Real; Ana Ardèvol; Imma Simón; Joan Vendrell
Journal:  Cytokine       Date:  2009-06-27       Impact factor: 3.861

2.  Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity.

Authors:  Mahmoud Ebrahimi; Majid Ghayour-Mobarhan; Samaneh Rezaiean; Maryam Hoseini; Seyyed Mohamad Reza Parizade; Fatemeh Farhoudi; Syyed Javad Hosseininezhad; Shima Tavallaei; Amirhosein Vejdani; Mohsen Azimi-Nezhad; Mohamad Taghi Shakeri; Mina Akbari Rad; Naser Mobarra; Seyyed Mohammad Reza Kazemi-Bajestani; Gordon A A Ferns
Journal:  Acta Cardiol       Date:  2009-06       Impact factor: 1.718

Review 3.  Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review.

Authors:  Paul E Marik; Joseph Varon
Journal:  Clin Cardiol       Date:  2009-07       Impact factor: 2.882

4.  Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 in lipopolysaccharide-stimulated RAW264.7 cells by carboxybutyrylated glucosamine takes place via down-regulation of mitogen-activated protein kinase-mediated nuclear factor-kappaB signaling.

Authors:  Niranjan Rajapakse; Moon-Moo Kim; Eresha Mendis; Se-Kwon Kim
Journal:  Immunology       Date:  2008-01-18       Impact factor: 7.397

5.  Associations of herbal and specialty supplements with lung and colorectal cancer risk in the VITamins and Lifestyle study.

Authors:  Jessie A Satia; Alyson Littman; Christopher G Slatore; Joseph A Galanko; Emily White
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

6.  Ginsenoside Re reduces insulin resistance through inhibition of c-Jun NH2-terminal kinase and nuclear factor-kappaB.

Authors:  Zhiguo Zhang; Xiaoying Li; Wenshan Lv; Yisheng Yang; Hong Gao; Jun Yang; Yun Shen; Guang Ning
Journal:  Mol Endocrinol       Date:  2007-09-20

7.  Association between ginseng intake and mortality: Kangwha cohort study.

Authors:  Sang-Wook Yi; Jae Woong Sull; Jae Seok Hong; John Alderman Linton; Heechoul Ohrr
Journal:  J Altern Complement Med       Date:  2009-08       Impact factor: 2.579

8.  Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals.

Authors:  Michelle A Micallef; Manohar L Garg
Journal:  Atherosclerosis       Date:  2008-09-27       Impact factor: 5.162

9.  The anti-inflammatory effects of methylsulfonylmethane on lipopolysaccharide-induced inflammatory responses in murine macrophages.

Authors:  Yoon Hee Kim; Dae Hwan Kim; Hwan Lim; Doo-Yeon Baek; Hyun-Kyung Shin; Jin-Kyung Kim
Journal:  Biol Pharm Bull       Date:  2009-04       Impact factor: 2.233

Review 10.  Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement.

Authors:  Jack Cuzick; Florian Otto; John A Baron; Powel H Brown; John Burn; Peter Greenwald; Janusz Jankowski; Carlo La Vecchia; Frank Meyskens; Hans Jörg Senn; Michael Thun
Journal:  Lancet Oncol       Date:  2009-05       Impact factor: 41.316

View more
  26 in total

1.  Use of glucosamine and chondroitin supplements in relation to risk of colorectal cancer: Results from the Nurses' Health Study and Health Professionals follow-up study.

Authors:  Elizabeth D Kantor; Xuehong Zhang; Kana Wu; Lisa B Signorello; Andrew T Chan; Charles S Fuchs; Edward L Giovannucci
Journal:  Int J Cancer       Date:  2016-07-18       Impact factor: 7.396

2.  Glucosamine Use, Inflammation, and Genetic Susceptibility, and Incidence of Type 2 Diabetes: A Prospective Study in UK Biobank.

Authors:  Hao Ma; Xiang Li; Tao Zhou; Dianjianyi Sun; Zhaoxia Liang; Ying Li; Yoriko Heianza; Lu Qi
Journal:  Diabetes Care       Date:  2020-01-27       Impact factor: 19.112

3.  Factors Associated with Multiple Biomarkers of Systemic Inflammation.

Authors:  Sandi L Navarro; Elizabeth D Kantor; Xiaoling Song; Ginger L Milne; Johanna W Lampe; Mario Kratz; Emily White
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-01-11       Impact factor: 4.254

4.  Associations of Dietary Long-Chain ω-3 Polyunsaturated Fatty Acids and Fish Consumption With Endometrial Cancer Risk in the Black Women's Health Study.

Authors:  Theodore M Brasky; Todd R Sponholtz; Julie R Palmer; Lynn Rosenberg; Edward A Ruiz-Narváez; Lauren A Wise
Journal:  Am J Epidemiol       Date:  2016-01-10       Impact factor: 4.897

5.  Long-chain omega-3 polyunsaturated fatty acid intake and risk of colorectal cancer.

Authors:  Elizabeth D Kantor; Johanna W Lampe; Ulrike Peters; Thomas L Vaughan; Emily White
Journal:  Nutr Cancer       Date:  2013-09-20       Impact factor: 2.900

6.  Long-chain ω-3 fatty acid intake and endometrial cancer risk in the Women's Health Initiative.

Authors:  Theodore M Brasky; Rebecca J Rodabough; Jingmin Liu; Michelle L Kurta; Lauren A Wise; Tonya S Orchard; David E Cohn; Martha A Belury; Emily White; JoAnn E Manson; Marian L Neuhouser
Journal:  Am J Clin Nutr       Date:  2015-03-04       Impact factor: 7.045

7.  Use of dietary supplements in relation to urinary phthalate metabolite concentrations: Results from the National Health and Nutrition Examination Survey.

Authors:  Megan E Romano; Kelli O'Connell; Mengmeng Du; Colin D Rehm; Elizabeth D Kantor
Journal:  Environ Res       Date:  2018-12-17       Impact factor: 6.498

8.  Use of glucosamine and chondroitin supplements and risk of colorectal cancer.

Authors:  E D Kantor; J W Lampe; U Peters; D D Shen; T L Vaughan; E White
Journal:  Cancer Causes Control       Date:  2013-03-26       Impact factor: 2.506

9.  Intake of long-chain ω-3 fatty acids from diet and supplements in relation to mortality.

Authors:  Griffith A Bell; Elizabeth D Kantor; Johanna W Lampe; Alan R Kristal; Susan R Heckbert; Emily White
Journal:  Am J Epidemiol       Date:  2014-02-03       Impact factor: 4.897

10.  Specialty supplement use and biologic measures of oxidative stress and DNA damage.

Authors:  Elizabeth D Kantor; Cornelia M Ulrich; Robert W Owen; Peter Schmezer; Marian L Neuhouser; Johanna W Lampe; Ulrike Peters; Danny D Shen; Thomas L Vaughan; Emily White
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-08-05       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.